Latest: Q4 2018 · from the cash-flow statements filed with the SEC
Free cash flow$809M in Q4 2018
Operating cash flow$1.7B
Capital spending−$888M
Free cash flow+$809M
Analysis
In Q4 2018, DOW Chemical generated $1.7B of operating cash flow and spent $888M on capital projects, leaving free cash flow of $809M. That is $4.5B more than in Q4 2017 (−$3.7B).
Operating cash flow was $1.7B against net income of $910M — 1.9× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$827M, payables −$498M, inventory +$307M.
Its cash conversion cycle was 85 days (receivables 54 + inventory 73 − payables 43).
Free cash flow
Operating cash flow less capital spending.Latest (Q4 2018): Operating cash flow $1.7B, Capital spending $888M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $10.1B; the largest uses were capital spending ($16.8B) and operating cash flow ($7.9B). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$2.8B
Debt$19.9B
Net debt$17.1B
Due within a year$340M
DOW Chemical funds itself: free cash flow was — over the last twelve months, and $2.8B of cash and investments stands against $19.9B of debt ($340M due within a year, 8.1× covered by cash).
Principal due in each year as disclosed in the annual report, against $2.8B of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q4 2018
54
73
43
85
Q3 2018
54
73
42
86
Q2 2018
51
69
40
81
Q1 2018
48
70
43
76
Q4 2017
39
61
37
63
Q3 2017
35
72
41
66
Every quarter
Quarter
Operating cash flow
Capital spending
Acquisitions
Dividends
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q4 2018
$1.7B
−$888M
—
−$553M
−$2.2B
$6.0M
$725M
$809M
Q3 2018
$647M
−$663M
−$20.0M
−$1.0B
−$292M
$21.0M
$1.4B
−$16.0M
Q2 2018
$1.7B
−$564M
—
−$1.1B
−$516M
$22.0M
$336M
$1.1B
Q1 2018
−$158M
−$423M
—
−$1.1B
−$54.0M
$63.0M
$1.0B
−$581M
Q4 2017
−$2.7B
−$935M
$47.0M
−$1.1B
−$71.0M
$45.0M
$2.2B
−$3.7B
Q3 2017
−$2.1B
−$660M
$31.0M
—
−$445M
$87.0M
−$2.2B
−$2.8B
DOW Chemical: income statement and cash flow
DOW Chemical, Q2 2026: revenue $12.1B (+20% year over year), operating margin 7.2%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.